Innovative education program to improve substance abuse prevention and treatment
Official title: Discovery to Commercialization Program for Substance Abuse Prevention and Treatment (D2C: SAPT)
Funded at Johns Hopkins University · NIH-11093401 · Data updated 2026-11-12
This study is all about helping scientists who work on Substance Use Disorders learn how to turn their research ideas into real-world solutions, with a special program at Johns Hopkins University that offers online courses and support to make that happen.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | July 15, 2022 |
| Project end | May 31, 2027 |
| Funding year | 2025 |
| Award (this year) | $321,078 |
| NIH project number | 5UE5DA056878-04 |
| Project ID | NIH-11093401 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals affected by substance use disorders who may benefit from innovative treatment approaches developed through this program.
✕Less likely to help
Patients who are not affected by substance use disorders or those who do not engage with the educational initiatives may not receive any benefit from this research.
What this research studies
This research focuses on developing and implementing an innovative entrepreneurship education program aimed at scientists working on Substance Use Disorders (SUDs). By providing tailored resources and training, the program seeks to empower these researchers to commercialize their ideas and create effective solutions for preventing and treating SUDs. The initiative includes the creation of a new Certificate in Entrepreneurship at Johns Hopkins University, which will feature asynchronous online modules designed specifically for SUD researchers. The goal is to foster a supportive community that enhances the translation of scientific discoveries into practical applications.
Why it matters
Potential benefit: If successful, this research could lead to the development of new and effective treatments for substance use disorders, ultimately improving patient outcomes.
How similar studies have gone: Other research initiatives have successfully implemented similar educational programs to foster innovation in healthcare, suggesting a promising potential for this approach.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Phan, Phillip — Johns Hopkins University
- Study coordinator: Phan, Phillip
Related research
Other NIH-funded projects on the same topics.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
-
Neurobiological signs of resilience and recovery from substance abuse in youth who faced childhood adversity
A long-term study will explore brain patterns in young people who faced childhood adversity to understand why some stay resilient and avoid substance problems.
-
Illuminating how brain peptides control withdrawal in methamphetamine use
A new NIH grant aims to build precise chemical tools to turn brain peptide signals on or off, helping people who are withdrawing from methamphetamine.
-
Molecular Pathways of Innate Immunity and Substance Abuse in NeuroHIV
A new project will explore how HIV and methamphetamine together cause brain inflammation, with the goal of understanding why some people living with HIV experience neurocognitive problems.
-
How neighborhood stigma and support relate to substance use and HIV risk for Black and Latino bisexual men
This project looks at how local stigma and supportive places in daily life relate to substance use and HIV risk among Black and Latino bisexual men.
-
How methamphetamine and immune signals affect the brain in people with HIV
This project tests whether methamphetamine together with HIV turns on a specific immune alarm pathway (cGAS/STING) in brain cells of people living with HIV who use methamphetamine.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.